Wen‐Mei Yu
-
- Nanoplatforms for cancer theranostics 5
-
- Porphyrin and Phthalocyanine Chemistry 4
-
- Photodynamic Therapy Research Studies 4
-
- Acute Myeloid Leukemia Research 3
-
- Pluripotent Stem Cells Research 2
- Mitochondrial Function and Pathology 2
-
- Pancreatic function and diabetes 2
-
- Synthesis and biological activity 1
- Journals
- Blood (4 papers)Cell stem cell (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- United StatesChinaCzechia
In The Last Decade
Wen‐Mei Yu
16 papers receiving 345 citations
Peers
Comparison fields: 5 of 56
- Inorganic Chemistry 48
- Biomedical Engineering 146
- Materials Chemistry 135
- Pulmonary and Respiratory Medicine 77
- Hematology 25
Countries citing papers authored by Wen‐Mei Yu
This map shows the geographic impact of Wen‐Mei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Mei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Mei Yu more than expected).
Fields of papers citing papers by Wen‐Mei Yu
This network shows the impact of papers produced by Wen‐Mei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Mei Yu. The network helps show where Wen‐Mei Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wen‐Mei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 4 | |
| 4 | 2020 | 88 | |
| 5 | 2020 | 75 | |
| 6 | 2020 | 11 | |
| 7 | 2019 | 37 | |
| 8 | 2019 | 53 | |
| 9 | 2019 | 8 | |
| 10 | 2018 | 32 | |
| 11 | 2018 | 7 | |
| 12 | 2014 | 0 | |
| 13 | 2014 | 1 | |
| 14 | 2012 | 1 | |
| 15 | 2011 | 4 | |
| 16 | 2011 | 4 | |
| 17 | 1999 | 1 |
About Wen‐Mei Yu
Wen‐Mei Yu is a scholar working on Hematology, Clinical Biochemistry and Biochemistry, having authored 17 papers that have together received 348 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Photodynamic Therapy Research Studies (4 papers), Porphyrin and Phthalocyanine Chemistry (4 papers), Acute Myeloid Leukemia Research (3 papers), Pluripotent Stem Cells Research (2 papers), Mitochondrial Function and Pathology (2 papers), Pancreatic function and diabetes (2 papers) and Synthesis and biological activity (1 paper). The work is most often cited by research in Inorganic Chemistry (48 citations), Biomedical Engineering (146 citations) and Materials Chemistry (135 citations). Wen‐Mei Yu has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Yunmei Liu, Hongyu Luo, Jun He, Jun He, Zhenhua Liu, Cheng‐Kui Qu, Qizhi Zhang, Yu Guo, Chunhui Xu and Yang Li. Their work appears in journals such as Blood, Cell stem cell and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.